This inventor holds 1 USPTO granted patent. Top assignee: University of Tsukuba. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Megumi Yashima: Innovator in Transdermal Drug Delivery
Introduction
Megumi Yashima is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of transdermal drug delivery systems. His innovative work focuses on improving the efficacy and safety of drug absorption through the skin.
Latest Patents
Yashima holds a patent for a "Nalfurafine-containing percutaneous absorption patch." This invention relates to a patch designed to deliver nalfurafine, a drug used for pain management, through the skin. The patch features a support, a drug layer, and a control layer that are laminated successively. The drug layer contains nalfurafine or its salts, ensuring a controlled level of drug permeation while preventing excessive absorption, even in compromised skin conditions. He has 1 patent to his name.
Career Highlights
Megumi Yashima is affiliated with the University of Tsukuba, where he conducts research and development in pharmaceutical sciences. His work has garnered attention for its potential to enhance patient care through innovative drug delivery methods.
Collaborations
Yashima collaborates with esteemed colleagues, including Hiroshi Nagase and Makiko Tada. Their combined expertise contributes to advancing research in the field of drug delivery systems.
Conclusion
Megumi Yashima's contributions to transdermal drug delivery highlight his role as an innovator in the pharmaceutical industry. His work promises to improve therapeutic outcomes for patients requiring effective pain management solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
